Adjuvanted Enterovirus 71 Vaccine Is Highly Effective in Infants and Children
Researchers assessed the efficacy of an adjuvanted enterovirus 71 (EV71) vaccine for the prevention of EV71-associated infections among infants and children.
Researchers assessed the efficacy of an adjuvanted enterovirus 71 (EV71) vaccine for the prevention of EV71-associated infections among infants and children.
Sandra Springer, MD, and Laura Marks, MD, PhD, highlight the need for a combined treatment approach for patients with drug-use associated infections.
Investigators assessed the efficacy of a novel microbiome therapeutic, SER-109, for the treatment of recurrent C difficile infection.
Researchers evaluated the safety and efficacy of the investigational, microbiota-based, live biotherapeutic RBX2660 for treatment of recurrent C difficile infection.
Researchers conducted a study to determine the rates of human papillomavirus (HPV) infection among adolescent girls and young women in New York City who received the HPV vaccine following its approval in 2007.
Investigators conducted a study to determine whether cytomegalovirus affects epigenetic age and immune dysregulation in healthy older adults who are asymptomatic.
To help clinicians and patients determine if antibodies protect against reinfection, the ACP discussed tests for diagnosing and estimating the prevalence of COVID-19.
During weeks 12-19 of 2020, the incidence of end-stage kidney disease decreased 20% compared with the same period in 2017-2019, according to a COVID-19 supplement to the US Renal Data System 2020 annual data report.
Investigators collected survey data on demographics, risk perception, and death rate to assess their impact on voluntary behaviors, such as time spent at home.
In today’s feature article, we talk with Ziyad Al-Aly, MD, of the Institute for Public Health in Washington, DC, who describes treating long-haulers as “America’s next big health crisis.”